Skip to main content

Drug Interactions between Benicar and lactobacillus rhamnosus gg / omega-3 polyunsaturated fatty acids

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between Benicar and lactobacillus rhamnosus gg / omega-3 polyunsaturated fatty acids. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Benicar

A total of 294 drugs are known to interact with Benicar.

lactobacillus rhamnosus gg / omega-3 polyunsaturated fatty acids

A total of 421 drugs are known to interact with lactobacillus rhamnosus gg / omega-3 polyunsaturated fatty acids.

  • Lactobacillus rhamnosus gg / omega-3 polyunsaturated fatty acids is in the drug class probiotics.
  • Lactobacillus rhamnosus gg / omega-3 polyunsaturated fatty acids is used to treat Dietary Supplementation.

Drug and food interactions

Moderate

olmesartan food

Applies to: Benicar (olmesartan)

If you are taking olmesartan you should avoid potassium-containing salt substitutes or over-the-counter potassium supplements without first talking to your doctor. This can cause high levels of potassium in your blood. High levels of potassium can cause weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs. Call your doctor at once if you have any of these symptoms.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer